Delcath Systems

DCTH

Delcath Systems, Inc. Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based …

Insider trades and stock quote 2022-2024

All insider trades at Delcath Systems

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
3/19/2024 BuySalamon, Steven A J. Director $3.7 $100,001
3/19/2024 BuyAharon, Gil Director $3.7 $100,001
12/12/2023 BuyVukovic, Vojo Chief Medical Officer $3.0 $120,000
12/8/2023 BuyMichel, Gerard J. Chief Executive Officer $2.9 $99,960
11/17/2023 BuyPennell, Sandra SVP of Finance, PFO and PAO $2.4 $72,900
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)